TNFSF14-LTBR pathway plays a vital role in immune responses in the TME of many types of cancer, but this pathway has not been reported in TME of colon cancer, suggesting it might be an important immunotherapeutic target for CRC treatment. This evidence concerns the gene LTBR and cancer.